BioAffinity Technologies Company Top Insiders

BioAffinity Technologies Management Team Effectiveness

The company has return on total asset (ROA) of (0.7171) % which means that it has lost $0.7171 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.4518) %, meaning that it created substantial loss on money invested by shareholders. BioAffinity Technologies' management efficiency ratios could be used to measure how well BioAffinity Technologies manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.97. The BioAffinity Technologies' current Return On Capital Employed is estimated to increase to -2.87. At this time, BioAffinity Technologies' Other Assets are most likely to decrease significantly in the upcoming years. The BioAffinity Technologies' current Fixed Asset Turnover is estimated to increase to 5.46, while Non Currrent Assets Other are projected to decrease to roughly 15.1 K. The current Common Stock Shares Outstanding is estimated to decrease to about 290.3 K. The current Net Loss is estimated to decrease to about (7.6 M)bioAffinity Technologies shows 3.15 percent of its outstanding shares held by insiders and 9.35 percent owned by other corporate entities. Some institutional investors establish a significant position in stocks such as BioAffinity Technologies in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BioAffinity Technologies, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

BioAffinity Technologies Workforce Comparison

BioAffinity Technologies Profit Margins

The company has Profit Margin (PM) of (2.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.59.

BioAffinity Technologies Insider Trading

BioAffinity Technologies Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as bioAffinity Technologies often depends on how effective the management is. BioAffinity Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioAffinity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioAffinity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.